C1446041||Serum mass profile
C0005516||biomarker
C0242379||lung cancer
C0005516||molecular biomarkers
C0242379||lung cancer
C0242481||pre-selection
C0040405||computed tomography
C0220908||screening
C1446041||serum mass profile
C0237401||individuals
C0242379||lung cancer
C1708335||healthy participants
C0281477||lung cancer screening program
C0178913||Blood samples
C0040405||computed tomography
C0040405||low-dose computed tomography
C0220908||screening program
C2607850||institution
C0020028||Medical University of Gdansk
C0032356||Poland
C1518101||MALDI-ToF mass spectrometry
C0229671||serum
C0936012||analysis
C0242379||lung cancer
C0599755||cohorts
C1519941||validation
C0936012||analyzed
C0574031||molecular components
C0229671||serum
C0030956||peptidome
C0242379||lung cancer
C0599755||cohort
C0006826||cancer
C3161035||model
C0599755||cohort
C0178913||sample sets
C1446041||serum mass profile
C0242379||lung cancer
C0005516||marker
C0242481||stand-alone preselecting tool
C0040405||low-dose computed tomography
C0220908||screening
C0220825||evaluation
C0034079||pulmonary nodules
C0220825||investigation